No registrations found.
ID
Source
Health condition
Long term induced seroprotection after fractional dose yellow fever vaccine
Sponsors and support
International Society of Travel Medicine
Intervention
Outcome measures
Primary outcome
Neutralizing antibody response ten years after yellow fever vaccination
Secondary outcome
none
Background summary
In this follow-up study, we measure neutralizing antibody titers after fractional dosing (1/5th) of yellow fever vaccine, compared to standard dose vaccination, ten years after primary vaccination
Study objective
Neutralizing antibody titers after fractional dosing of yellow fever vaccine are comparable to standard dose vaccination, ten years after primary vaccination
Study design
one time point (ten years after the initial trial, after primary yellow fever vaccination)
Intervention
Blood sample (one)
A.H.E. Roukens
Leids Universitair Medisch Centrum
Leiden
The Netherlands
071-5262613 (secretariaat Infectieziekten)
a.h.e.roukens@lumc.nl
A.H.E. Roukens
Leids Universitair Medisch Centrum
Leiden
The Netherlands
071-5262613 (secretariaat Infectieziekten)
a.h.e.roukens@lumc.nl
Inclusion criteria
Participants of a non-inferiority randomized controlled trial conducted in 2007-2008, investigating the immune response after yellow fever vaccine in fractional dose intradermally administered
Exclusion criteria
immune disorder developed after the initial trial, booster yellow fever vaccination after the initial trial
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL5528 |
| NTR-old | NTR7094 |
| Other | METC LUMC : P16.205 |